Name | ÀüÁö¹Î (¿¬±¸Á¶±³¼ö) |
---|---|
Tel | 031-290-5954 |
jjimjeon@gmail.com |
1. Jeon J., et al., Blockade of Activin Receptor IIB Protects Arthritis Pathogenesis by Non-Amplification of Activin A-ACVR2B-NOX4 Axis Pathway. Advanced Science. 2023
2. Han SJ., et al., Schisandrol A Suppresses Catabolic Factor Expression by Blocking NF-¥êB Signaling in Osteoarthritis. Pharmaceuticals. 2021
3. Jeon et al., TRIM24-RIP3 axis perturbation accelerates osteoarthritis pathogenesis. Ann Rheum Dis. 2020
4. Song EK*, Jeon J* et al., ITGBL1 modulates integrin activity to promote cartilage formation and protect against arthritis. Sci Transl Med. 2018
5. Jeon et al., 3'-Sialyllactose protects against osteoarthritic development by facilitating cartilage homeostasis. J Cell Mol Med. 2017
6. Regulation of the catabolic cascade in osteoarthritis by the zinc-ZIP8-MTF1 axis. Cell. 2014
7. NAMPT (visfatin), a direct target of hypoxia-inducible factor-2¥á, is an essential catabolic regulator of osteoarthritis. Ann Rheum Dis. 2015
8. Misexpression of Dickkopf-1 in endothelial cells, but not in chondrocytes or hypertrophic chondrocytes, causes defects in endochondral ossification. J Bone Miner Res. 2012
9. Jeon et al. Cytokine-like 1 knock-out mice (Cytl1-/-) show normal cartilage and bone development but exhibit augmented osteoarthritic cartilage destruction. J Biol Chem. 2011
Patent
1. 3'-½Ã¾Ë¸±¶ôÅä¿À½º ¶Ç´Â ÀÌÀÇ À¯µµÃ¼¸¦ À¯È¿¼ººÐÀ¸·Î ÇÔÀ¯ÇÏ´Â ÅðÇ༺°üÀý¿°ÀÇ ¿¹¹æ ¶Ç´Â Ä¡·á¿ë Á¶¼º¹°. ´ëÇѹα¹Æ¯Çã µî·Ï: 10-1773066
2. 6'-½Ã¾Ë¸±¶ôÅä¿À½º ¶Ç´Â ÀÌÀÇ À¯µµÃ¼¸¦ À¯È¿¼ººÐÀ¸·Î ÇÔÀ¯ÇÏ´Â ÅðÇ༺°üÀý¿°ÀÇ ¿¹¹æ ¶Ç´Â Ä¡·á¿ë Á¶¼º¹°. ´ëÇѹα¹Æ¯Çã µî·Ï: 10-1773067
Presentation at international conference
1. Jeon et al., 3'-Sialyllactose pevents osteoarthritic development by suppression of catabolic factor expression. 2018 Osteoarthritis Research Society International. Liverpool, UK
Grant
1. ÀÌ°øºÐ¾ß ±âÃÊ¿¬±¸»ç¾÷
- »ç¾÷±â°£ : 2022. 03 - 2025. 02.
¸ñ·Ï
|